Government of the Democratic Republic of the Congo Report issue

Government Phase 3 Phase 4
Founded: Kinshasa Congo (2003)

Organization Overview

First Clinical Trial
2008
NCT01772940
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

L'Institut National de Recherche Biomédicale RDC | Ministère de la Santé de la RDC | Ministry of Public Health, Democratic Republic of the Congo | Ministry of Public Health, Hygiene and Prevention, Kinshasa

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hemorrhagic Fever, Ebola (Phase 3)

Malaria (Phase 4)

Monkeypox (Phase 3)

Smallpox (Phase 3)

Trypanosomiasis (Phase 4)

Trypanosomiasis, African (Phase 4)

Virus Diseases (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 20